71 related articles for article (PubMed ID: 17987534)
1. [New polymorphisms in the PSA promoter in patients with prostate carcinoma].
Schostak M; Braun C; Krause H; Miller K; Kempkensteffen C; Hinz S; Strenziok R; Blana A; Schrader M
Aktuelle Urol; 2007 Nov; 38(6):465-72. PubMed ID: 17987534
[TBL] [Abstract][Full Text] [Related]
2. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
[TBL] [Abstract][Full Text] [Related]
3. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.
Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T
Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393
[TBL] [Abstract][Full Text] [Related]
4. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer.
Yang Q; Shan L; Segawa N; Nakamura M; Nakamura Y; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2001; 21(1A):197-200. PubMed ID: 11299734
[TBL] [Abstract][Full Text] [Related]
5. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Carvalho R; Lopes C
Prostate; 2002 Sep; 53(1):88-94. PubMed ID: 12210484
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of ETV6 in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
[TBL] [Abstract][Full Text] [Related]
7. [A case-control study on JWA promoter -76G-->C polymorphism and the susceptibility of bladder cancer].
Wu W; Li CP; Chen R; Cao XJ; Li AP; Wang Y; Yang KH; Qian LX; Liu QZ; Li ZL; Zhou JW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):648-52. PubMed ID: 16331563
[TBL] [Abstract][Full Text] [Related]
8. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
9. The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.
Marangoni K; Araújo TG; Neves AF; Goulart LR
BMC Cancer; 2008 Sep; 8():273. PubMed ID: 18823560
[TBL] [Abstract][Full Text] [Related]
10. Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer.
Yang QF; Sakurai T; Shan L; Yu Z; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
J Hum Genet; 2000; 45(6):363-6. PubMed ID: 11185746
[TBL] [Abstract][Full Text] [Related]
11. Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.
Hirata H; Hinoda Y; Kikuno N; Suehiro Y; Shahryari V; Ahmad AE; Tabatabai ZL; Igawa M; Dahiya R
J Urol; 2009 Apr; 181(4):1907-12. PubMed ID: 19237173
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
[TBL] [Abstract][Full Text] [Related]
13. Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer.
Pampalakis G; Scorilas A; Sotiropoulou G
Clin Biochem; 2008 May; 41(7-8):591-7. PubMed ID: 18222179
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
17. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
Sävblom C; Giwercman A; Malm J; Halldén C; Lundin K; Lilja H; Giwercman Y
Int J Androl; 2009 Oct; 32(5):479-85. PubMed ID: 18336535
[TBL] [Abstract][Full Text] [Related]
19. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
20. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
